Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105382 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Styliani Sarrou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, Common Variable Immunodeficiency, Heterozygote. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients with predominantly antibody deficiencies (PADs) display hypogammaglobulinemia with a high prevalence of infections, along with autoimmune manifestations, benign and malignant lymphoproliferation and granulomatous disease. It is noteworthy that PAD patients, even those with defects in the same causative genes, display a variable clinical phenotype, suggesting that additional genetic polymorphisms, located in either immune-related or non-immune-related genes, may affect their clinical and laboratory phenotype. In this context, we analyzed 80 PAD patients, including 70 with common variable immunodeficiency (CVID) for SERPINA1 defects, in order to investigate the possible contribution to PAD clinical phenotype. Ten CVID patients carried heterozygous pathogenic SERPINA1 defects with normal alpha-1 antitrypsin levels. Interestingly, the presence of the Z allele (rs28929474), which was found in three patients, was significantly associated with liver disease; hepatic complications were also observed in patients carrying the p.Leu23Gln (rs1379209512) and the p.Phe76del (rs775982338) alleles. Conversely, no correlation of SERPINA1 defective variants with respiratory complications was observed, although patients with pathogenic variants exhibit a reduced probability of developing autoimmune diseases. Therefore, we recommend SERPINA1 genetic analysis in PAD in order to identify patients with a higher risk for liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.
- Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece.
- Department of Immunology and Histocompatibility, "Evaggelismos" General Hospital, 10676 Athens, Greece.
ORCID-Profile: Styliani Sarrou, Ioanna Voulgaridi, Katerina Dadouli, Christos Hadjichristodoulou, Matthaios Speletas
Zitieren
APA
Sarrou, S., Voulgaridi, I., Fousika, A., Dadouli, K., Margaritopoulou, O., Kakkas, I., Hadjichristodoulou, C., Kalala, F., & Speletas, M. (2024). Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105382
Vancouver
Sarrou S, Voulgaridi I, Fousika A, Dadouli K, Margaritopoulou O, Kakkas I, et al. Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105382
BibTeX
@article{Sarrou2024,
author = {Sarrou, Styliani and Voulgaridi, Ioanna and Fousika, Athanasia and Dadouli, Katerina and Margaritopoulou, Olympia and Kakkas, Ioannis and Hadjichristodoulou, Christos and Kalala, Fani and Speletas, Matthaios},
title = {Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105382}
}
EUVIMED